This seems to be the bulk of the money making options for the team. Note they are only making money above $1.40
Named Executives and Directors
Shares Granted
Glenn D. Bolduc 5,442,490
Dr. William J. McGann 1,498,972
Roger P. Deschenes 1,058,498
Dr. Darryl K. Jones 1,258,498
Michael C. Turmelle 640,949
Howard Safir 303,399
Robert P. Liscouski 806,798
John A. Keating 303,399
Todd A. Silvestr 730,949
Brenda L. Baron 730,949
Estate of Joseph E. Levangie 525,099
Total
13,300,000
On July 1, 2015, at the 2015 Annual Meeting of Stockholders, the September 2012 amendment was approved by our stockholders. Each of the options has an exercise price of $1.40 per share. One-half of options granted to each of Messrs. Bolduc, Deschenes, Silvestri and Ms. Baron were immediately exercisable and the other one-half became exercisable on September 7, 2013. One-third of the new options granted to each of Drs. McGann and Jones were immediately exercisable, one-third became exercisable on September 7, 2013, and the remaining one-third became exercisable on September 7, 2014. Options granted to Messrs. Turmelle, Safir, Liscouski, Keating and the Estate of Mr. Levangie are immediately exercisable in full. All of the options will expire on September 6, 2022, subject to earlier expiration with respect to Messrs. Bolduc, McGann, Deschenes, Jones, Silvestri and Ms. Baron in connection with the termination or cessation of their respective employment with the company.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.